(Q26830804)

English

Is sustained virological response a marker of treatment efficacy in patients with chronic hepatitis C viral infection with no response or relapse to previous antiviral intervention?

scientific article

In more languages

Statements

scholarly article

1 reference

1 reference

26 October 2022

systematic review

1 reference

PubMed publication ID

Is sustained virological response a marker of treatment efficacy in patients with chronic hepatitis C viral infection with no response or relapse to previous antiviral intervention? (English)

1 reference

1 reference

27 October 2020

modelling biological systems

1 reference

19 September 2019

1 reference

3 November 2019

antiviral agent

1 reference

27 October 2020

chronic hepatitis C

1 reference

based on heuristic

inferred from abstract

life expectancy

1 reference

PubMed publication ID

Christian Gluud

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24349487%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Kurinchi Selvan Gurusamy

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24349487%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24349487%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Brian R Davidson

5

object named as

Brian R Davidson

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24349487%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Ronald L Koretz

3

object named as

Ronald L Koretz

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24349487%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Victoria B Allen

4

object named as

Victoria B Allen

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24349487%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Andrew Kenneth Burroughs

6

object named as

Andrew K Burroughs

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24349487%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

language of work or name

1 reference

publication date

2013

1 reference

12 December 2013

10 references

23 March 2019

21 March 2019

22 June 2019

19 September 2019

3 November 2019

1 July 2020

27 October 2020

22 October 2022

25 October 2022

26 October 2022

12 references

23 March 2019

21 March 2019

22 June 2019

19 September 2019

3 November 2019

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24349487%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 July 2020

27 October 2020

22 October 2022

25 October 2022

26 October 2022

8

2 references

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24349487%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

12

2 references

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24349487%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

e83313

2 references

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24349487%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

copyright license

Creative Commons Attribution 4.0 International

10 references

Europe PubMed Central

23 March 2019

Europe PubMed Central

21 March 2019

Europe PubMed Central

22 June 2019

Europe PubMed Central

19 September 2019

Europe PubMed Central

3 November 2019

Europe PubMed Central

1 July 2020

Europe PubMed Central

27 October 2020

Europe PubMed Central

22 October 2022

Europe PubMed Central

25 October 2022

Europe PubMed Central

26 October 2022

copyright status

0 references

on focus list of Wikimedia project

0 references

Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3861485

7 April 2017

Ribavirin plus interferon versus interferon for chronic hepatitis C

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3861485

7 April 2017

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3861485

7 April 2017

Grading quality of evidence and strength of recommendations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3861485

7 April 2017

Clinical practice. Chronic hepatitis C infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3861485

7 April 2017

Modelling in economic evaluation: an unavoidable fact of life

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3861485

7 April 2017

Evolving epidemiology of hepatitis C virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3861485

7 April 2017

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3861485

7 April 2017

Comparative effectiveness of antiviral treatment for hepatitis C virus infection in adults: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3861485

28 September 2017

Efficacy and tolerability of telaprevir for chronic hepatitis virus C genotype 1 infection: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3861485

28 September 2017

Preliminary study of two antiviral agents for hepatitis C genotype 1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3861485

28 September 2017

Effects of a sustained virologic response on outcomes of patients with chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3861485

28 September 2017

Evidence at a glance: error matrix approach for overviewing available evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3861485

28 September 2017

Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3861485

28 September 2017

Is sexual contact a major mode of hepatitis C virus transmission?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3861485

28 September 2017

Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3861485

28 September 2017

The history of the "natural history" of hepatitis C (1968-2009).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3861485

28 September 2017

Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3861485

28 September 2017

A comparison of aprotinin and lysine analogues in high-risk cardiac surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3861485

28 September 2017

Hepatology may have problems with putative surrogate outcome measures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3861485

28 September 2017

Interferon for interferon naive patients with chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3861485

28 September 2017

Risk and management of blood-borne infections in health care workers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3861485

28 September 2017

Methodology and Reports of Systematic Reviews and Meta-analyses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3861485

28 September 2017

Mother to child transmission of hepatitis C virus: rate of infection and risk factors

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0083313

21 January 2018

Natural history of acute symptomatic hepatitis type C.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0083313

21 January 2018

High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0083313

21 January 2018

Serum level of IP-10 increases predictive value of IL28B polymorphisms for spontaneous clearance of acute HCV infection

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0083313

21 January 2018

Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany--a 25-year multicenter study

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0083313

21 January 2018

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0083313

21 January 2018

Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0083313

21 January 2018

The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0083313

21 January 2018

Long-term cohort study of chronic hepatitis C according to interferon efficacy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0083313

21 January 2018

Favorable prognosis of chronic hepatitis C after interferon therapy by long-term cohort study

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0083313

21 January 2018

Prediction of sustained virological response to combination therapy with pegylated interferon alfa and ribavirin in patients with genotype 3 chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0083313

21 January 2018

Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients coinfected with HIV and hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0083313

21 January 2018

The idolatry of the surrogate

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0083313

21 January 2018

Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3861485

28 November 2018

Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. Evidence-Based Medicine Working Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/24349487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced risk of hepatocellular carcinoma after interferon therapy in aged patients with chronic hepatitis C is limited to sustained virological responders

1 reference

https://pubmed.ncbi.nlm.nih.gov/24349487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0083313

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24349487%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

2013PLoSO...883313G

0 references

release_r776tnxrrbawxjajo33irasrfa

0 references

PMC publication ID

2 references

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24349487%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

PubMed publication ID

2 references

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24349487%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26830804&oldid=1953104112"